735 related articles for article (PubMed ID: 17252575)
1. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma.
Arush MW; Israel O; Postovsky S; Militianu D; Meller I; Zaidman I; Sapir AE; Bar-Shalom R
Pediatr Blood Cancer; 2007 Dec; 49(7):901-5. PubMed ID: 17252575
[TBL] [Abstract][Full Text] [Related]
2. Roles of positron emission tomography with fluorine-18-deoxyglucose in the detection of local recurrent and distant metastatic sarcoma.
Johnson GR; Zhuang H; Khan J; Chiang SB; Alavi A
Clin Nucl Med; 2003 Oct; 28(10):815-20. PubMed ID: 14508272
[TBL] [Abstract][Full Text] [Related]
3. 18-fluoro-2-deoxyglucose positron emission tomography in detecting residual/recurrent nasopharyngeal carcinomas and comparison with magnetic resonance imaging.
Yen RF; Hung RL; Pan MH; Wang YH; Huang KM; Lui LT; Kao CH
Cancer; 2003 Jul; 98(2):283-7. PubMed ID: 12872346
[TBL] [Abstract][Full Text] [Related]
4. 2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial.
Buchmann I; Reinhardt M; Elsner K; Bunjes D; Altehoefer C; Finke J; Moser E; Glatting G; Kotzerke J; Guhlmann CA; Schirrmeister H; Reske SN
Cancer; 2001 Mar; 91(5):889-99. PubMed ID: 11251940
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone.
Ghanem N; Uhl M; Brink I; Schäfer O; Kelly T; Moser E; Langer M
Eur J Radiol; 2005 Jul; 55(1):41-55. PubMed ID: 15950100
[TBL] [Abstract][Full Text] [Related]
6. EUS, PET, and CT scanning for evaluation of pancreatic adenocarcinoma.
Mertz HR; Sechopoulos P; Delbeke D; Leach SD
Gastrointest Endosc; 2000 Sep; 52(3):367-71. PubMed ID: 10968852
[TBL] [Abstract][Full Text] [Related]
7. Value of FDG positron emission tomography in conjunction with MR imaging for evaluating therapy response in patients with musculoskeletal sarcomas.
Bredella MA; Caputo GR; Steinbach LS
AJR Am J Roentgenol; 2002 Nov; 179(5):1145-50. PubMed ID: 12388489
[TBL] [Abstract][Full Text] [Related]
8. Fusion image of positron emission tomography and computed tomography for the diagnosis of local recurrence of rectal cancer.
Fukunaga H; Sekimoto M; Ikeda M; Higuchi I; Yasui M; Seshimo I; Takayama O; Yamamoto H; Ohue M; Tatsumi M; Hatazawa J; Ikenaga M; Nishimura T; Monden M
Ann Surg Oncol; 2005 Jul; 12(7):561-9. PubMed ID: 15889211
[TBL] [Abstract][Full Text] [Related]
9. Combined positron emission tomography/computed tomography imaging of recurrent thyroid cancer.
Zimmer LA; McCook B; Meltzer C; Fukui M; Bascom D; Snyderman C; Townsend DW; Johnson JT
Otolaryngol Head Neck Surg; 2003 Feb; 128(2):178-84. PubMed ID: 12601311
[TBL] [Abstract][Full Text] [Related]
10. FDG PET for the study of primary hepatic malignancies in children.
Mody RJ; Pohlen JA; Malde S; Strouse PJ; Shulkin BL
Pediatr Blood Cancer; 2006 Jul; 47(1):51-5. PubMed ID: 16078228
[TBL] [Abstract][Full Text] [Related]
11. Importance of adrenal incidentaloma in patients with a history of malignancy.
Frilling A; Tecklenborg K; Weber F; Kühl H; Müller S; Stamatis G; Broelsch C
Surgery; 2004 Dec; 136(6):1289-96. PubMed ID: 15657589
[TBL] [Abstract][Full Text] [Related]
12. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation.
Anderson GS; Brinkmann F; Soulen MC; Alavi A; Zhuang H
Clin Nucl Med; 2003 Mar; 28(3):192-7. PubMed ID: 12592125
[TBL] [Abstract][Full Text] [Related]
13. Endometriosis with FDG uptake on PET.
Jeffry L; Kerrou K; Camatte S; Metzger U; Lelièvre L; Talbot JN; Lecuru F
Eur J Obstet Gynecol Reprod Biol; 2004 Dec; 117(2):236-9. PubMed ID: 15541863
[TBL] [Abstract][Full Text] [Related]
14. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging.
Gallowitsch HJ; Kresnik E; Gasser J; Kumnig G; Igerc I; Mikosch P; Lind P
Invest Radiol; 2003 May; 38(5):250-6. PubMed ID: 12750613
[TBL] [Abstract][Full Text] [Related]
15. FDG-PET in the clinical management of Hodgkin lymphoma.
Hutchings M; Eigtved AI; Specht L
Crit Rev Oncol Hematol; 2004 Oct; 52(1):19-32. PubMed ID: 15363464
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of fluorodeoxyglucose positron emission tomography in the management of soft-tissue sarcomas.
Lucas JD; O'Doherty MJ; Wong JC; Bingham JB; McKee PH; Fletcher CD; Smith MA
J Bone Joint Surg Br; 1998 May; 80(3):441-7. PubMed ID: 9619933
[TBL] [Abstract][Full Text] [Related]
17. Therapy monitoring of presacral recurrences after high-dose irradiation: value of PET, CT, CEA and pain score.
Engenhart R; Kimmig BN; Strauss LG; Höver KH; Romahn J; Haberkorn U; van Kaick G; Wannenmacher M
Strahlenther Onkol; 1992 Apr; 168(4):203-12. PubMed ID: 1574769
[TBL] [Abstract][Full Text] [Related]
18. [A case of curative resection of local recurrence after abdominosacral resection of recurrent rectal cancer based on the diagnosis of PET/CT fusion images].
Ohue M; Sekimoto M; Fukunaga H; Ikenaga M; Yamamoto H; Ikeda M; Yasui M; Takayama H; Hata Y; Kitani K; Seki Y; Hujie Y; Higuchi I; Monden M
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1829-32. PubMed ID: 14619531
[TBL] [Abstract][Full Text] [Related]
19. [Retroperitoneal sarcomas: 2. Surgical and complementary treatment].
Bonvalot S
J Chir (Paris); 1999 Jun; 136(2):61-6. PubMed ID: 10480053
[TBL] [Abstract][Full Text] [Related]
20. Colorectal liver metastases: CT, MR imaging, and PET for diagnosis--meta-analysis.
Bipat S; van Leeuwen MS; Comans EF; Pijl ME; Bossuyt PM; Zwinderman AH; Stoker J
Radiology; 2005 Oct; 237(1):123-31. PubMed ID: 16100087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
